JP2025506783A5 - - Google Patents
Info
- Publication number
- JP2025506783A5 JP2025506783A5 JP2024549676A JP2024549676A JP2025506783A5 JP 2025506783 A5 JP2025506783 A5 JP 2025506783A5 JP 2024549676 A JP2024549676 A JP 2024549676A JP 2024549676 A JP2024549676 A JP 2024549676A JP 2025506783 A5 JP2025506783 A5 JP 2025506783A5
- Authority
- JP
- Japan
- Prior art keywords
- gusacitinib
- crystalline
- hcl salt
- salt according
- ray powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN202211009506 | 2022-02-23 | ||
| IN202211009506 | 2022-02-23 | ||
| IN202211028117 | 2022-05-16 | ||
| IN202211028117 | 2022-05-16 | ||
| IN202211031922 | 2022-06-03 | ||
| IN202211031922 | 2022-06-03 | ||
| IN202211053997 | 2022-09-21 | ||
| IN202211053997 | 2022-09-21 | ||
| IN202311006675 | 2023-02-02 | ||
| IN202311006675 | 2023-02-02 | ||
| IN202311007408 | 2023-02-06 | ||
| IN202311007408 | 2023-02-06 | ||
| PCT/US2023/013668 WO2023164024A1 (en) | 2022-02-23 | 2023-02-23 | Solid state forms of gusacitinib |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025506783A JP2025506783A (ja) | 2025-03-13 |
| JP2025506783A5 true JP2025506783A5 (cg-RX-API-DMAC7.html) | 2025-11-04 |
Family
ID=85640884
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024549676A Pending JP2025506783A (ja) | 2022-02-23 | 2023-02-23 | グサシチニブの固体形態 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250171448A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4482836A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025506783A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240151808A (cg-RX-API-DMAC7.html) |
| CA (1) | CA3244694A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023164024A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202510870A (zh) * | 2023-07-27 | 2025-03-16 | 美商自由生物有限公司 | Jak/syk抑制劑之組合物及固體形式 |
| WO2025020171A1 (en) * | 2023-07-27 | 2025-01-30 | Libertas Bio, Inc. | Crystalline forms of a jak/syk inhibitor |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2748166T3 (pl) * | 2011-08-23 | 2019-05-31 | Asana Biosciences Llc | Związki pirimido-pirydazynonowe oraz ich zastosowanie |
| WO2018187294A1 (en) * | 2017-04-03 | 2018-10-11 | Asana Biosciences, Llc | Pyrimido-pyridazinone compound combinations, methods, kits and formulations thereof |
| EP3875078A1 (en) * | 2020-03-06 | 2021-09-08 | Dompe' Farmaceutici S.P.A. | Compounds for the treatment of covid-19 |
-
2023
- 2023-02-23 KR KR1020247030857A patent/KR20240151808A/ko active Pending
- 2023-02-23 EP EP23711320.4A patent/EP4482836A1/en active Pending
- 2023-02-23 JP JP2024549676A patent/JP2025506783A/ja active Pending
- 2023-02-23 US US18/839,779 patent/US20250171448A1/en active Pending
- 2023-02-23 WO PCT/US2023/013668 patent/WO2023164024A1/en not_active Ceased
- 2023-02-23 CA CA3244694A patent/CA3244694A1/en active Pending